Yingxin Ren
-
- interferon and immune responses 3
-
- Nanoplatforms for cancer theranostics 6
-
- Ferroptosis and cancer prognosis 4
-
- Cancer, Lipids, and Metabolism 2
-
- Extracellular vesicles in disease 3
-
- Cancer Immunotherapy and Biomarkers 2
- Inflammatory Biomarkers in Disease Prognosis 2
-
- Software Reliability and Analysis Research 1
- Journals
- Advanced Functional Materials (1 paper)Chemical Engineering Journal (2 papers)ACS Applied Materials & Interfaces (1 paper)
- Partner nations
- China
In The Last Decade
Yingxin Ren
14 papers receiving 338 citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Biomaterials 61
- Immunology 81
- Biomedical Engineering 142
- Pulmonary and Respiratory Medicine 91
- Cancer Research 41
Countries citing papers authored by Yingxin Ren
This map shows the geographic impact of Yingxin Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingxin Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingxin Ren more than expected).
Fields of papers citing papers by Yingxin Ren
This network shows the impact of papers produced by Yingxin Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingxin Ren. The network helps show where Yingxin Ren may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yingxin Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 10 | |
| 5 | Gut microbiota modulate CD8 + T cell immunity in gastric cancer through Butyrate/GPR109A/HOPXbreakdown → | 2024 | 56 |
| 6 | 2023 | 2 | |
| 7 | 2023 | 40 | |
| 8 | 2023 | 28 | |
| 9 | 2022 | 17 | |
| 10 | 2022 | 28 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 57 | |
| 13 | 2022 | 52 | |
| 14 | 2022 | 25 | |
| 15 | 2009 | 9 |
About Yingxin Ren
Yingxin Ren is a scholar working on Software, Cancer Research and Immunology, having authored 15 papers that have together received 342 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (6 papers), Ferroptosis and cancer prognosis (4 papers), interferon and immune responses (3 papers), Extracellular vesicles in disease (3 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Software Reliability and Analysis Research (1 paper). The work is most often cited by research in Biomaterials (61 citations), Immunology (81 citations) and Biomedical Engineering (142 citations). Yingxin Ren has collaborated with scholars based in China. Frequent co-authors include Zhian Chen, Yanfeng Hu, Zhenyuan Li, Weihong Guo, Huilin Huang, Guoxin Li, Zhenhao Li, Zhenhao Li, Bingxia Zhao and Lingzhi Wang. Their work appears in journals such as Advanced Functional Materials, Chemical Engineering Journal and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.